Selected Grants
The Duke Preparing Research scholars In bioMEdical sciences (PRIME): Cancer Research Program
ResearchPreceptor · Awarded by National Cancer Institute · 2023 - 2028Identifying and exploiting therapeutic vulnerabilities of tumor-host interactions that drive bone-to-meninges breast cancer metastasis
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2028Duke Preparing Research Scholars in Biomedical Sciences- Post-Baccalaureate Research Education Program
Inst. Training Prgm or CMEMentor · Awarded by National Institute of General Medical Sciences · 2022 - 2027Medical Scientist Training Program
Inst. Training Prgm or CMEPreceptor · Awarded by National Institute of General Medical Sciences · 2022 - 2027Duke ACS Institutional Research Grant
ResearchSignificant Contributor · Awarded by American Cancer Society, Inc. · 2024 - 2026Hematology & Transfusion Medicine (T32)
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 1975 - 2026e Window trial to evaluate molecular response of PI3K inhibition with copanlisib in relapsed or refractory adult B-cell acute lymphoblastic leukemia
Clinical TrialPrincipal Investigator · Awarded by Bayer HealthCare, LLC · 2021 - 2026R01 Defining and targeting a novel pathway for central nervous system leptomeningeal metastasis
ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2020 - 2025Duke CTSA (TL1) Year 5
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024R21 Novel use of PI3K inhibition to prevent recurrence of B-cell acute lymphoblastic leukemia
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2024A DUAL ROLE OF INTEGRIN ALPHA-3 IN BREAST CANCER CNS METASTASIS & CHEMORESISTANCE (F31)
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2023Defining the Rules of Breast Cancer Cell Traffic Through Bone
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2022Medical Scientist Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1997 - 2022Targeting Dormant Breast Cancer Micrometastases to Prevent Disease Relapse
ResearchPrincipal Investigator · Awarded by American Cancer Society, Inc. · 2019 - 2022Studying the Effects of Combined E-selectin and CXCR4 Inhibition on Breast Cancer Cell Immune Recognition
ResearchPrincipal Investigator · Awarded by GlycoMimetics, Inc · 2020 - 2021Targeting sphingosine kinase 2 for the treatment of multiple myeloma
Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2015 - 2021Role of Osteopontin in Induction of Leukemia Dormancy in the Bone Marrow
ResearchPrincipal Investigator · Awarded by American Cancer Society, Inc. · 2014 - 2018Studying the Effects of Combined E-Selectin/CXCR4 Inhibition on Breast Cancer Cell Metastasis, Growth and Immune Regulation
ResearchPrincipal Investigator · Awarded by GlycoMimetics, Inc · 2016 - 2017Investigation of PI3Kdelta inhibitor activity in mouse xenograft models of pre-B acute lymphoblastic leukemia ALL
ResearchPrincipal Investigator · Awarded by Gilead Sciences, Inc. · 2016 - 2017Investigation of CX-01 in InVitro Pre-Clinical Models of Leukemia
ResearchPrincipal Investigator · Awarded by Cantex Pharmaceuticals, Inc. · 2015 - 2016Regulation of Leukemia Cell Dormancy by the Bone Marrow Microenvironment
ResearchPrincipal Investigator · Awarded by Gabrielle's Angel Foundation · 2014 - 2015External Relationships
- Deerfield Institute
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.